UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000003076
Receipt No. R000003667
Scientific Title Phase II study to evaluate the safety and the efficacy of CBD (Bortezomib, Cyclophosphamide, Dexamethasone) regimen for the patients with relapsed and/or refractory multiple myeloma
Date of disclosure of the study information 2010/02/01
Last modified on 2012/02/14 14:09:39

No. Disposal Last modified on Item of update
1 Insert 2010/01/22 14:48:42
2 Update 2012/02/14 14:09:39 Name of person sending information
Organization
Division name
Address
Organization
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.


Contact us.